Ibuprofen ANDA Status Backed By Dr. Reddy’s; Foreign-Sources Defended
This article was originally published in The Tan Sheet
Executive Summary
Dr. Reddy's Labs claims "there is no need whatsoever" to include ibuprofen 200 mg in the Internal Analgesic, Antipyretic & Anti-rheumatic Drug Products Tentative Final Monograph, in recent comments to FDA